首航節能(002665.SZ):黃卿樂被動減持股份數量達1262.4萬股 減持期屆滿
格隆匯12月16日丨首航節能(002665.SZ)公佈,2019年12月16日,公司收到黃卿樂出具的《關於被動減持股份數量過半暨減持計劃期限屆滿的告知函》。獲悉廣州證券對黃卿樂持有的首航節能無限售流通股於2019年12月12日進行違約處置被動減持388.0222萬股,成交均價為3.37元/股;2019年12月13日進行違約處置被動減持49756股,成交均價為3.39元/股。
截至目前,黃卿樂被動減持股份數量為1262.4萬股,其股份減持計劃數量已過半,減持期限已經屆滿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.